Ülke: İrlanda
Dil: İngilizce
Kaynak: HPRA (Health Products Regulatory Authority)
Praziquantel; Fenbendazole
Chanelle Pharmaceuticals Manufacturing Limited
QP52AA51; QP52AC13
Praziquantel; Fenbendazole
50/500 mg/tablet
Tablet
CAM: Companion Animal Medicine as defined in relevant national legislation
Cats, Dogs
praziquantel, combinations; fenbendazole
Endoparasiticide
Authorised
2001-05-04
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Zantel Cat and Dog Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION 3 PHARMACEUTICAL FORM Tablet. A round buff-coloured tablet with a quarter score. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Dogs and cats 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES A broad spectrum anthelmintic for the treatment of mixed infections of gastrointestinal nematodes and cestodes in dogs and cats. Zantel Cat and Dog tablets may also be used as an aid in the control of_ Giardia_ protozoa in dogs and_ Aelurostrongylus_ _abstrusus_ lungworm infection in cats. 4.3 CONTRAINDICATIONS Do not use in kittens less than 8 weeks of age. ACTIVE SUBSTANCES (PER TABLET): Praziquantel 50.0 mg Fenbendazole 500.0 mg Ascarids _Toxocara cati (adult)_ _Toxascaris leonina (immature, adult)_ Hookworms _Uncinaria stenocephala (immature, adult)_ _Ancylostoma caninum (immature, adult)_ Whipworms _Trichuris vulpis (adult)_ Tapeworms _Echinococcus granulosus_ _Echinococcus multilocularis_ _Dipylidium caninum_ _Taenia spp._ _Mesocestoides spp_ H E A L T H P R O D U C T S R E G U L A T O R Y A U T H O R I T Y ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ _D_ _a_ _t_ _e_ _ _ _P_ _r_ _i_ _n_ _t_ _e_ _d_ _ _ _2_ _7_ _/_ _0_ _7_ _/_ _2_ _0_ _1_ _5_ _C_ _R_ _N_ _ _ _7_ _0_ _2_ _1_ _3_ _3_ _9_ _p_ _a_ _g_ _e_ _ _ _n_ _u_ _m_ _b_ _e_ _r_ _:_ _ _ _1_ 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES None. 4.5 SPECIAL PRECAUTIONS FOR USE SPECIAL PRECAUTIONS FOR USE IN ANIMALS None. SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE VETERINARY MEDICINAL PRODUC Belgenin tamamını okuyun